• Swedish-based biotech company specializing in T cell therapies, Annoca, has raised approximately $46M in a Venture round with support from Ramsbury Invest AB

Source Of Information: 

Disclaimer:

• All content provided by Let's Talk Family Office℠ is for informational and educational purposes only and should not be taken as legal or professional advice. The information contained in this content is not maintained or endorsed or guaranteed by Let's Talk Family Office℠ or it's associates. Always seek legal or professional advice from a professional.